Skip to main content
. 2017 Oct 5;8(61):103499–103508. doi: 10.18632/oncotarget.21498

Table 3. Genotype distributions of the IL-17A polymorphisms between the IS patients and the control group.

Polymorphisms Controls Cases Logistic regression
n=443 (%) n=392 (%) OR (95% CI) P value
rs1974226
CC 394 (88.9) 359 (91.6) 1.00 (Ref)
CT 48 (10.9) 31 (7.9) 0.84 (0.40∼1.76) 0.643
TT 1 (0.2) 2 (0.5) 2.11 (0.14∼32.99) 0.595
CT/TT vs. CC 0.89 (0.43∼1.82) 0.744
CC/CT vs. TT 2.27 (0.21∼25.09) 0.505
rs3748067
CC 364 (82.2) 323 (82.4) 1.00 (Ref)
CT 77 (17.4) 65 (16.6) 1.02 (0.59∼1.77) 0.951
TT 2 (0.4) 4 (1.0) 1.49 (0.15∼14.81) 0.735
CT/TT vs. CC 1.04 (0.60∼1.78) 0.898
CC/CT vs. TT 1.48 (0.15∼14.74) 0.736
rs2275913
AA 121 (27.3) 72 (18.4) 1.00 (Ref)
GA 235 (53.1) 231 (58.9) 1.72 (1.05∼2.81) 0.032
GG 87 (19.6) 89 (22.7) 1.99 (1.08∼3.67) 0.028
GA/GG vs. AA 1.78 (1.11∼2.86) 0.017
AA/GA vs. GG 1.36 (0.82∼2.25) 0.229

OR, odds ratio; CI, confidence interval; Ref, reference category; , Adjusted by age, gender, hypertension, diabetes mellitus, TG, LDL-C, HDL-C, and TCH.